Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![JohnZidar Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1115443829161713666.png) John Zidar [@JohnZidar](/creator/twitter/JohnZidar) on x 5908 followers
Created: 2025-07-16 11:53:23 UTC

$CGTX - Cognition Therapeutics' 
🔹Positive Clinical Data from Zervimesine (CT1812) Phase X Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC 
🔹The drug demonstrated remarkable efficacy with treatment improvements of XX% in behavioral outcomes, XX% in daily living activities and XX% in cognitive fluctuations

👆 XXXX% PreM/ $XXXX

![](https://pbs.twimg.com/media/Gv-hyB9WMAAIKlu.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945451696244543536/c:line.svg)

**Related Topics**
[$cgtx](/topic/$cgtx)

[Post Link](https://x.com/JohnZidar/status/1945451696244543536)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

JohnZidar Avatar John Zidar @JohnZidar on x 5908 followers Created: 2025-07-16 11:53:23 UTC

$CGTX - Cognition Therapeutics' 🔹Positive Clinical Data from Zervimesine (CT1812) Phase X Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC 🔹The drug demonstrated remarkable efficacy with treatment improvements of XX% in behavioral outcomes, XX% in daily living activities and XX% in cognitive fluctuations

👆 XXXX% PreM/ $XXXX

XXXXX engagements

Engagements Line Chart

Related Topics $cgtx

Post Link

post/tweet::1945451696244543536
/post/tweet::1945451696244543536